Geron Faces Investor Suit After FDA Halts Clinical Trial
Geron Corp. was hit with a shareholder class action Friday in California federal court accusing the drugmaker of improperly touting the prospects of its sole drug candidate before the U.S. Food...To view the full article, register now.
Already a subscriber? Click here to view full article